Skip to content

A Web-based Survey to Assess Disease Burden among Self-diagnosed Patients with Hidradenitis Suppurativa in Japan

A Web-based Survey to Assess Disease Burden among Self-diagnosed Patients with Hidradenitis Suppurativa in Japan - A Web-based Survey to Assess Disease Burden among Self-diagnosed Patients with Hidradenitis Suppurativa in Japan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049713
Enrollment
400
Registered
2022-12-07
Start date
2022-12-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hidradenitis Suppurativa

Interventions

None listed

Sponsors

AbbVie GK.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Meet all 3 self-diagnosed criteria based on the JDA guideline *Presence of nodules (inflamed or noninflamed), sinus tracts (inflamed or noninflamed), follicular papule/pustule (folliiculitis), abscesses, scarring (atrophic, mesh-like, red, hypertrophic, linear, or bridged) *More than 2 clinical signs at different areas, including axilla, genitofemoral area, perineum, gluteal area, and infra-mammary area of women (under or between breasts) *Recurrent painful or suppurating lesions more than 2x/6 months -Aged 16+ years at screening -Have willingness and ability to provide informed consent

Exclusion criteria

Exclusion criteria: -Have been diagnosed with HS by physician -Did not answer all questionnaire

Design outcomes

Primary

MeasureTime frame
DLQI total scores DLQI domain scores Sociodemographic characteristics Health-related information HSSA scores WPAI: HS scores HiSQOL scores SF-36 scores

Countries

Japan

Contacts

Public ContactTakeshi Akiyama

IQVIA Solutions Japan K.K. Real World Evidence Solutions & HEOR

takeshi.akiyama@iqvia.com070-1640-7263

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026